<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04209608</url>
  </required_header>
  <id_info>
    <org_study_id>RC19_0416</org_study_id>
    <nct_id>NCT04209608</nct_id>
  </id_info>
  <brief_title>Observational Study on Respiratory Impact of High-frequency Jet Ventilation (JVHF) in Interventional Radiology (RI)</brief_title>
  <acronym>Pulmojet</acronym>
  <official_title>Observational Study on Respiratory Impact of High-frequency Jet Ventilation (JVHF) in Interventional Radiology (RI)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nantes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Jet ventilation is used in interventional radiology to reduce respiratory movement and
      facilitate tumor destruction. The purpose of this study is to describe the respiratory impact
      of this technique
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Use imaging and respiratory data to describe the impact of JVHF during tumor thermoablation
      procedures
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">March 12, 2020</start_date>
  <completion_date type="Anticipated">February 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>evaluate the respiratory impact after the use of JVHF after thermoablation of a solid abdominal tumour.</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>Respiratory complication rate.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Describe the number of ventilatory disorders</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>Score Radiological Atelectasis Score (RAS) of Richter Larsen - RAS: 0, clear lung field; 1, plate like atelectasis or slight infiltration; 2, partial atelectasis; 3, lobar atelectasis; 4, bilateral lobar atelectasis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Describe the incidence of hypoxemia during JVHF</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>Difference between oxygen saturation at the end of the procedure and at the beginning of the procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Describe the incidence of hypercapnia at the time of a JVHF</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>Difference between end of procedure and beginning of procedure capnia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Describe the incidence of barotraumatic pulmonary lesions at the time of a JVHF</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>Presence of barotraumatic pulmonary lesions on the imaging</description>
  </secondary_outcome>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Anesthesia Complication</condition>
  <eligibility>
    <study_pop>
      <textblock>
        This study will be offered to patients benefiting from thermoablation of abdominal tumors
        under JVHF. Recruitment will take place during the pre-anesthetic consultation.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Major patient

          -  Patient benefiting from an abdominal tumor thermoablation procedures

          -  Patient who gave consent

          -  Patient with a social protection scheme

        Exclusion Criteria:

          -  Pulmonary thermoablation procedures

          -  Thermoablation of abdominal tumors required a transpleural passage

          -  Patient under guardianship or curatorship

          -  Patient not understanding French
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Nathalie Desfriches Doria</last_name>
    <phone>02 53 48 28 35</phone>
    <phone_ext>+(33)</phone_ext>
    <email>Nathalie.desfrichesdoria@chu-nantes.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Nantes University Hospital</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nathalie desfriches doria</last_name>
      <phone>+(33) 02 40 08 75 34</phone>
      <email>Nathalie.desfrichesdoria@chu-nantes.fr</email>
    </contact>
    <investigator>
      <last_name>Nathalie desfriches doria</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>December 20, 2019</study_first_submitted>
  <study_first_submitted_qc>December 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 24, 2019</study_first_posted>
  <last_update_submitted>March 13, 2020</last_update_submitted>
  <last_update_submitted_qc>March 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

